"PinnacleHealth Women's Cancer Center is a Women's Health Clinic located in Harrisburg. Visit our website to learn more about the conditions we treat and the services we offer. Schedule your appointment today. UPMC is committed to protecting our communities from the spread of COVID-19. We continue to require people who come to any UPMC facility to wear a facemask that covers their nose and mouth and to practice other preventative efforts like social distancing, even if fully vaccinated."

During the past decade, Pinnacle Health Cancer Institute conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pinnacle Health Cancer Institute" #1 sponsor was "Abramson Cancer Center at Penn Medicine" with 1 trials, followed by "Bryan Schneider, MD" with 1 trials sponsored, "MacroGenics" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "Stemline Therapeutics, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pinnacle Health Cancer Institute" #1 collaborator was "Hoosier Cancer Research Network" with 1 trials as a collaborator, "Patient-Centered Outcomes Research Institute" with 1 trials as a collaborator, "Strategic Research Initiative Grant through IUSCC" with 1 trials as a collaborator, "Vera Bradley Foundation for Breast Cancer" with 1 trials as a collaborator and "Walther Cancer Institute" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Pinnacle Health Cancer Institute" are "Breast Cancer" (3 trials), "Advanced Breast Cancer" (1 trials), "HER-2 Positive Breast Cancer" (1 trials), "Malignant Neoplasm of Breast" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Pinnacle Health Cancer Institute" in a lesser frequency.

Most popular intervention types in "Pinnacle Health Cancer Institute" are "Drug" (3 trials), "Other" (2 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Elacestrant" (1 trials), "Genomically Directed Monotherapy" (1 trials), "Margetuximab" (1 trials), "Observation/Standard Therapy" (1 trials) and "Photon" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pinnacle Health Cancer Institute" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Pinnacle Health Cancer Institute". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Pinnacle Health Cancer Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Pinnacle Health Cancer Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".